(Q54426389)

29 May 2018

title

Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy. (English)

1 reference

29 May 2018

Maria Dolores Sanchez-niño

author

1

1 reference

29 May 2018

Jose M Valdivielso

6

1 reference

29 May 2018

Peter Mathieson

5

Peter W Mathieson

1 reference

29 May 2018

Moin A Saleem

4

Moin A Saleem

1 reference

29 May 2018

Ana B Sanz

Ana B Sanz

2

0 references

Alberto Ortiz

Alberto Ortiz

10

0 references

author name string

Susana Carrasco

3

1 reference

29 May 2018

Marta Ruiz-Ortega

7

1 reference

29 May 2018

Marta Ruiz-Ortega

8

1 reference

29 May 2018

Jesus Egido

9

1 reference

29 May 2018

language of work or name

English

0 references

publication date

26 May 2010

1 reference

29 May 2018

Nephrology Dialysis Transplantation

published in

1 reference

29 May 2018

volume

26

1 reference

29 May 2018

issue

6

1 reference

29 May 2018

page(s)

1797-1802

1 reference

29 May 2018

Fabry's Disease: Alpha-Galactosidase Deficiency

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Cellular and tissue localization of globotriaosylceramide in Fabry disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Inflammation and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Antiproteinuric effect of oral paricalcitol in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Elevated globotriaosylsphingosine is a hallmark of Fabry disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

21 January 2018

A slit in podocyte death

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

The MIF receptor CD74 in diabetic podocyte injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Differential effects of vitamin D analogs on vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

The spectrum of podocytopathies: a unifying view of glomerular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

Extracellular matrix metabolism in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ306

21 January 2018

Identifiers

DOI

10.1093/NDT/GFQ306

1 reference

29 May 2018

PubMed ID

20504837

1 reference

29 May 2018